Impact of Superselective Transarterial Infusion Therapy of High-Dose Cisplatin on Maxillary Cancer with Orbital Invasion

References

1. 1.↵
   1. Saikawa S

   . Report of head and neck cancer registry of Japan clinical statistics of registered patients, 2002. Jpn J Head Neck Cancer 2006;32(suppl):1–14
2. 2.↵
   1. Perez CA,
   2. Brady LW

   1. Persons JT,
   2. Mendenhall WM,
   3. Stringer SP,
   4. et al

   . Nasal cavity and paranasal sinuses. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia: Lippincott-Raven; 1977:941–59
3. 3.↵
   1. Yoshimura R,
   2. Shibuya H,
   3. Ogura I,
   4. et al

   . Trimodal combination therapy for maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2002;53:656–63

   PubMedWeb of Science
4. 4.↵
   1. Robbins KT,
   2. Storniolo AM,
   3. Kerber C,
   4. et al

   . Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364–71

   PubMed
5. 5.↵
   1. Robbins KT,
   2. Storniolo AM,
   3. Kerber C,
   4. et al

   . Phase I study of highly selective supradose cisplatin infusion for head and neck cancer. J Clin Oncol 1994;12:2113–20

   Abstract/FREE Full Text
6. 6.↵
   1. Robbins KT,
   2. Vicario D,
   3. Seagren S,
   4. et al

   . A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419–22

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Mames RN,
   2. Snady-McCoy L,
   3. Guy J,
   4. et al

   . Central retinal and posterior ciliary artery occlusion after particle embolization of the external carotid artery system. Ophthalmology 1991;98:527–31

   PubMed
8. 8.↵
   1. Yokoyama J

   . Usefulness of CT-angiography for superselective intra-arterial chemotherapy for advanced head and neck cancers [in Japanese]. Gan To Kagaku Ryoho 2002;29:2302–06

   PubMed
9. 9.↵
   1. Terayama N,
   2. Sanada J,
   3. Matsui O,
   4. et al

   . Feeding artery of laryngeal and hypopharyngeal cancers: role of the superior thyroid artery in superselective intraarterial chemotherapy. Cardiovasc Intervent Radiol 2006;29:536–43

   CrossRefPubMed
10. 10.↵
    1. Shiga K,
    2. Yokoyama J,
    3. Hashimoto S,
    4. et al

    . Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head and Neck Surg 2007;136:1003–09

    CrossRef
11. 11.↵
    1. Homma A,
    2. Oridate N,
    3. Suzuki F,
    4. et al

    . Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses. Cancer 2009;115:4705–14

    CrossRefPubMed
12. 12.↵
    1. Samant S,
    2. Robbins KT,
    3. Vang M,
    4. et al

    . Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg 2004;30:948–55
13. 13.↵
    1. Nibu K,
    2. Sugasawa M,
    3. Asai M,
    4. et al

    . Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 2002;94:1476–82

    CrossRefPubMed
14. 14.↵
    1. Fujishiro Y,
    2. Nakao K,
    3. Watanabe K,
    4. et al

    . A new aspect of tri-modal therapy with superselective intra-arterial chemotherapy in maxillary sinus carcinoma. Acta Otolaryngol Suppl 2007;559:151–56

    PubMed
15. 15.↵
    1. Teicher BA,
    2. Holden SA,
    3. Kelley MJ,
    4. et al

    . Characterization of a human squamous cell carcinoma cell line resistance to cis-diamminedichloroplatinum (II). Cancer Res 1987;47:388–89

    Abstract/FREE Full Text
16. 16.↵
    1. Von Hoff DD,
    2. Clark GM,
    3. Weiss GR,
    4. et al

    . Use of in vivo dose response effects to select antineoplastics for high dose or regional administration regimens. J Clin Oncol 1986;4:1827–34

    Abstract
17. 17.↵
    1. Robbins KT,
    2. Fontanesi J,
    3. Wong S,
    4. et al

    . A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head and Neck Surg 1996;122:853–57
18. 18.↵
    1. Le QT,
    2. Fu KK,
    3. Kaplan MJ,
    4. et al

    . Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2002;46:541–49
19. 19.↵
    1. Los G,
    2. Blommaert A,
    3. Barton R,
    4. et al

    . Selective intraarterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation. Cancer Chemother Pharmacol 1995;37:150–54

    CrossRefPubMed
20. 20.↵
    1. Nagai N,
    2. Hotta K,
    3. Yamamura H,
    4. et al

    . Effect of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity. Cancer Chemother Pharmacol 1995;36:404–10

    PubMedWeb of Science
21. 21.↵
    1. Hirosawa A,
    2. Niitani H,
    3. Hayashibara K,
    4. et al

    . Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum platinum and vindesine. Cancer Chemother Pharmacol 1989;23:255–58

    CrossRefPubMed
22. 22.↵
    1. Nakasato T,
    2. Katoh K,
    3. Sone M,
    4. et al

    . Superselective continuous arterial infusion chemotherapy through the superficial temporal artery for oral cavity tumors. AJNR Am J Neuroradiol 2000;21:1917–22

    Abstract/FREE Full Text
23. 23.↵
    1. Tsurumaru D,
    2. Kuroiwa T,
    3. Yabuuti H,
    4. et al

    . Efficacy of intra-arterial infusion chemotherapy for head and neck cancers using coaxial catheter technique: initial experience. Cardiovasc Intervent Radiol 2007;30:207–11

    CrossRefPubMed